The incidence of Parkinsonism in patients with type 1 Gaucher disease: data from the ICGG Gaucher Registry
about
Enzyme replacement and substrate reduction therapy for Gaucher diseaseImiglucerase in the treatment of Gaucher disease: a history and perspectiveUnderstanding the natural history of Gaucher diseaseGaucher disease and comorbidities: B-cell malignancy and parkinsonismLysosomal integral membrane protein-2: a new player in lysosome-related pathologyAmbroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cellsParkinson disease in Gaucher disease.The French Gaucher's disease registry: clinical characteristics, complications and treatment of 562 patients.Eliglustat maintains long-term clinical stability in patients with Gaucher disease type 1 stabilized on enzyme therapy.Comparison of Parkinson risk in Ashkenazi Jewish patients with Gaucher disease and GBA heterozygotes.The link between the GBA gene and parkinsonismThe European Gaucher Alliance: a survey of member patient organisations' activities, healthcare environments and concerns.Hyposmia and cognitive impairment in Gaucher disease patients and carriersLoss of glucocerebrosidase 1 activity causes lysosomal dysfunction and α-synuclein aggregation.Gaucher-Associated Parkinsonism.Glucocerebrosidase activity in Parkinson's disease with and without GBA mutationsThe neurobiology of glucocerebrosidase-associated parkinsonism: a positron emission tomography study of dopamine synthesis and regional cerebral blood flowHaploinsufficiency of cathepsin D leads to lysosomal dysfunction and promotes cell-to-cell transmission of α-synuclein aggregatesAge-specific Parkinson disease risk in GBA mutation carriers: information for genetic counselingClinical course and prognosis in patients with Gaucher disease and parkinsonismThe association between ß-glucocerebrosidase mutations and parkinsonismGlucocerebrosidase mutations and the pathogenesis of Parkinson disease.Genetic convergence of Parkinson's disease and lysosomal storage disorders.Gaucher disease: the metabolic defect, pathophysiology, phenotypes and natural history.Long-term treatment outcomes in Gaucher disease.New Directions in Gaucher Disease.The Complicated Relationship between Gaucher Disease and Parkinsonism: Insights from a Rare Disease.Selective imaging of internalized proteopathic α-synuclein seeds in primary neurons reveals mechanistic insight into transmission of synucleinopathies.The history and accomplishments of the ICGG Gaucher registry.Connecting Gaucher and Parkinson Disease: Considerations for Clinical and Research Genetic Counseling Settings.The contribution of mutant GBA to the development of Parkinson disease in Drosophila.Parkinsonism in Inherited Metabolic Disorders: Key Considerations and Major Features
P2860
Q24187121-2ADAF41D-63AA-4413-902A-37FA8B2DAA7EQ24631426-480D6F4B-B760-4B2B-8D22-C243978033D2Q26865974-0EB7E127-1A4D-46E3-A3CD-3771232A67FEQ27002301-8710640A-81DE-40A0-81DE-26E99B3A2CFEQ28305187-E5F9115D-66E0-4D79-B298-94666B5AE2B1Q28308084-AD3950DD-23C7-4D82-B607-4A536223995FQ30852543-CA4CE0ED-337D-4D33-A9D1-AFC4DAE4C760Q33403714-9EEAFC62-A544-4030-9B5D-170CC01051B3Q33615625-67A03BA9-5B00-49B0-AC5C-249BCD1FEB8DQ33849233-8B9348E4-2D0D-4C61-9EA5-11A0942120B2Q34077492-D82FC377-49B2-4FDA-8E5B-2CC6F46FE131Q34151422-72712268-EF07-40D8-B0E0-A1623D285BA3Q34300690-A837E5B0-99F9-4B3A-9F3F-EA476B129F21Q35152964-64A54EE6-B491-47A2-90F9-4CA7A4C02D15Q35851610-DDAE1ABE-8BB1-4303-A22C-BACBC57997D4Q36041420-52F01ED8-1096-43F4-9A7F-B90895017CC7Q36124421-472D054D-3B1B-452D-ACC6-1BC4E159D6EAQ36246469-06DF08DD-3D10-4A0F-BB72-191F3CB56975Q36460324-B3DA1F34-AE6D-4F3F-BB2C-76099646EE7AQ36794066-9B6982EB-F70F-404F-9845-733645B50282Q38118169-155497DE-018C-4E51-97DF-A28807CF92CAQ38161987-AB05A8D8-0B41-42D0-9BEF-C154EB1502AFQ38237560-7E163109-61C3-4DF1-9D77-35778CBF46C3Q38262722-54C44694-C84D-4DC1-B4D2-A3C4E9F7A773Q38533851-0E8B0EBF-8E0F-4732-A742-0C43C7B9C24DQ38905996-8F6297FF-251D-4EEF-AA44-CD5176F2A9F2Q39148146-3BEB9893-6110-427F-B5BB-22D15E3051E8Q41378010-C03EDEDE-71C2-48F1-9499-3990AB8A263DQ41652308-670A3151-8DC8-4D3B-AF1C-1F06C741FA79Q48191413-9BE9BA54-06B4-4896-9DA2-94E81CAAC080Q52848620-C068A99E-F66B-4713-B9B3-1C4E7AF44423Q58122613-0550EDD2-1A83-4D66-84FF-898700C909C5
P2860
The incidence of Parkinsonism in patients with type 1 Gaucher disease: data from the ICGG Gaucher Registry
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The incidence of Parkinsonism ...... from the ICGG Gaucher Registry
@ast
The incidence of Parkinsonism ...... from the ICGG Gaucher Registry
@en
type
label
The incidence of Parkinsonism ...... from the ICGG Gaucher Registry
@ast
The incidence of Parkinsonism ...... from the ICGG Gaucher Registry
@en
prefLabel
The incidence of Parkinsonism ...... from the ICGG Gaucher Registry
@ast
The incidence of Parkinsonism ...... from the ICGG Gaucher Registry
@en
P2093
P2860
P1476
The incidence of Parkinsonism ...... from the ICGG Gaucher Registry
@en
P2093
Andrea R Gwosdow
Ari Zimran
Barry Rosenbloom
Edwin Kolodny
J Alexander Cole
Jeff M Bronstein
John S Taylor
Manisha Balwani
Neal J Weinreb
Swati Sathe
P2860
P304
P356
10.1016/J.BCMD.2010.10.006
P577
2010-11-10T00:00:00Z